enGene (NASDAQ: ENGN) is a late-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs, whose lead product candidate, detalimogene voraplasmid, is being evaluated in an ongoing pivotal study for patients with non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (Cis) who are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene’s proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. For more information, visit enGene.com.RoleAs a Senior Medical Science Liaison, Field Medical Affairs, you will engage in scientific exchange and collaborate with Uro-Oncology disease experts and product information as well as research initiatives. We provide scientific and/or medical expertise by thoroughly understanding Uro Oncology as a therapeutic area serving as a scientific/medical resource. We present scientific and clinical data and disease state awareness in response to requests for information to therapeutic area specialists, practitioners, investigators, research coordinators, site personnel and internal partners.Preference for candidates located on the East (EST)Essential Duties & Responsibilities
This site uses cookies to deliver our services and to show you relevant ads and job listings. By using our site, you acknowledge that you have read and understand our Privacy Policy, and our Terms of Service.